Transdiagnostic Internet-delivered intervention for children and adolescents with anxiety and depressive disorders: a randomized controlled trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 41545507.
- Also identified by DOI 10.1038/s41746-026-02341-x and PMC identifier 12902070.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Internalizing problems are the most common mental health problems encountered in youths. This study investigated the efficacy of a transdiagnostic Internet-delivered intervention (REBTonAd), delivered over 6 weeks. Our study included Romanian youths (aged 11-17) with a primary diagnosis of an anxiety and/or depressive disorder. Eligible participants (N = 106; M<sub>age</sub> = 12.83, SD = 1.63) were randomly assigned to the REBTonAd group (n = 53) or the waitlist condition (WL) (n = 53), with outcomes assessed at baseline, post-test, and 6-month follow-up. At the post-test, the remission rate and clinical reliable change indices were higher in the REBTonAd group. Internalizing problems were reduced more in the REBTonAd group, with a moderate effect size (standardized mean difference = -0.60, 95% CI -0.96 to -0.25). Future research needs to test the effectiveness of this intervention compared to disorder-specific treatments and investigate its cost-effectiveness. This trial was prospectively registered at ClinicalTrials.gov (NCT04179526).